Revenue FY2025
—
Net Income
$(117.0M)
EPS (Basic)
$-16.95
Net Margin
—
ROE
-73.4%
Total Equity
$159.0M
Shares Out
9M
Adicet Bio, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
Insider Transactions
Reading stored insider transactions…